Question 1

What are the potential benefits of using otamixaban compared to heparin for my procedure?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the The SEPIA-PCI Trial: Otamixaban in Comparison to Heparin in Subjects Undergoing Non-Urgent Percutaneous Coronary Intervention clinical trial (NCT00133731). Contact the study team or your healthcare provider for specific answers.

Question 2

How will my safety be monitored during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the The SEPIA-PCI Trial: Otamixaban in Comparison to Heparin in Subjects Undergoing Non-Urgent Percutaneous Coronary Intervention clinical trial (NCT00133731). Contact the study team or your healthcare provider for specific answers.

Question 3

What side effects should I be aware of with otamixaban?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the The SEPIA-PCI Trial: Otamixaban in Comparison to Heparin in Subjects Undergoing Non-Urgent Percutaneous Coronary Intervention clinical trial (NCT00133731). Contact the study team or your healthcare provider for specific answers.

Question 4

How does this trial fit with my current treatment plan?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the The SEPIA-PCI Trial: Otamixaban in Comparison to Heparin in Subjects Undergoing Non-Urgent Percutaneous Coronary Intervention clinical trial (NCT00133731). Contact the study team or your healthcare provider for specific answers.

Question 5

What happens if I experience any complications during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the The SEPIA-PCI Trial: Otamixaban in Comparison to Heparin in Subjects Undergoing Non-Urgent Percutaneous Coronary Intervention clinical trial (NCT00133731). Contact the study team or your healthcare provider for specific answers.

Question 6

Are there any additional visits or tests required if I participate?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the The SEPIA-PCI Trial: Otamixaban in Comparison to Heparin in Subjects Undergoing Non-Urgent Percutaneous Coronary Intervention clinical trial (NCT00133731). Contact the study team or your healthcare provider for specific answers.

What this study is about